"Chemotherapy sensitivity testing" of biopsy predicts tumor response Jan 28, 2003 New techniques to evaluate tumors' responses to chemotherapeutic agents promise a future of personalized cancer management, many oncologists are beginning to believe. http://www.oncolink.com/resources/article.cfm?c=3&s=8&ss=23&Year=2003&Month=1&id=9326
Gemcitabine-cisplatin regimen successful for relapsed ovarian cancer January 21, 2003 Using ex vivo drug sensitivity profiles, researchers have identified a novel chemotherapy regimen effective in treating relapsed, multidrug-resistant ovarian cancer http://www.oncolink.com/resources/article.cfm?c=3&s=8&ss=23&Year=2003&Month=1&id=9301